Home > Research > Publications & Outputs > Copy number polymorphism in Fcgr3 predisposes t...
View graph of relations

Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published
  • Timothy J. Aitman
  • Rong Dong
  • Timothy J. Vyse
  • Penny J. Norsworthy
  • Michelle D. Johnson
  • Jennifer Smith
  • Jonathan Mangion
  • Cheri Roberton-Lowe
  • Amy J. Marshall
  • Enrico Petretto
  • Gurjeet Bhangal
  • Sheetal G. Patel
  • Kelly Sheehan-Rooney
  • Mark Duda
  • Paul R. Cook
  • David J. Evans
  • Jan Domin
  • Jonathan Flint
  • Joseph J. Boyle
  • Charles D. Pusey
  • H. Terence Cook
Close
<mark>Journal publication date</mark>16/02/2006
<mark>Journal</mark>Nature
Volume439
Number of pages5
Pages (from-to)851-855
Publication StatusPublished
<mark>Original language</mark>English

Abstract

Identification of the genes underlying complex phenotypes and the definition of the evolutionary forces that have shaped eukaryotic genomes are among the current challenges in molecular genetics1, 2, 3. Variation in gene copy number is increasingly recognized as a source of inter-individual differences in genome sequence and has been proposed as a driving force for genome evolution and phenotypic variation3, 4, 5. Here we show that copy number variation of the orthologous rat and human Fcgr3 genes is a determinant of susceptibility to immunologically mediated glomerulonephritis. Positional cloning identified loss of the newly described, rat-specific Fcgr3 paralogue, Fcgr3-related sequence (Fcgr3-rs), as a determinant of macrophage overactivity and glomerulonephritis in Wistar Kyoto rats. In humans, low copy number of FCGR3B, an orthologue of rat Fcgr3, was associated with glomerulonephritis in the autoimmune disease systemic lupus erythematosus. The finding that gene copy number polymorphism predisposes to immunologically mediated renal disease in two mammalian species provides direct evidence for the importance of genome plasticity in the evolution of genetically complex phenotypes, including susceptibility to common human disease.